Monthly Pulse (May '21)

Markets - 05.05.2021 - 6 min read time

Economic Outlook

Vaccination programs are progressing steadily across the globe: over 7.5% of the world population have received at least one dose. More and more countries are lifting mobility restrictions. However, as India is going through a devastating wave of infections, we are reminded that the greatest risks are still coming from the pandemic-related developments, and from how effective the vaccines are against new COVID-19 strains, since lack of effect would mean new lockdowns, prolonged travel restrictions and a slower economic recovery. 

Tactical Asset Allocation

Liqudity Neutral
Bonds Underweight
Equities Neutral
Alternative Investments Overweight






EU GDP figures showed that the output of  the currency union contracted by 0.6% in the first quarter of 2021 relative to the previous quarter. Meanwhile, the US GDP grew 1.6% over the same period. This reflects the difference of approaches to the pandemic handling: while the EU prolongs lockdowns to contain the pandemic, the US rapidly distributes the vaccine, and gradually eases restrictions.

Similar patterns can be traced out in the PMI data, although the more recent estimates, April flash PMIs, suggest that  business activity is expanding in both regions. The Indexes showed a steady expansion in both Manufacturing and Service activity in the US (60.6 and 63.1, respectively) and a strong expansion in Manufacturing, accompanied by a modest expansion in Services, in Eurozone (63.3 and 50.3, respectively). This, together with the accelerating vaccination pace and the massive pent-up demand, gives a reason to expect a significant growth return in the second quarter.
As CPIs are starting to pick up, 2.6% year on year in the US in March and 1.6% (preliminary) year on year in the EU in April, inflation concerns become more relevant. The Bank of Canada was the first major central bank to start tapering. However, Fed and ECB are maintaining the accommodative stance, as the unemployment levels are still elevated and the increase in price growth rate is likely to be temporary.

Fixed Income

US 10-year Treasury yields traded in the range of 1.5%-1.7% in April, briefly exceeding 1.7% before retreating and finishing the month just over 1.63%. We expect the yields to continue to fluctuate in this range in the upcoming weeks. By the end of the year, US 10-year yields are likely to exceed 2%.
Credit spreads are around their lowest levels in over a decade. High yield still remains a more attractive option for investors, than investment grade, but valuations are becoming high, and the belief that HY will keep delivering good results is waning. The main risk currently is the possibility of a sustained spike in inflation which would push government bond yields rapidly up, similar to what happened in February.

We keep our duration short and are overweight credit risk especially in Emerging Markets.


Aside from the lagging energy sector, overall, April was a positive month for equities, supported by stellar earnings, strong macroeconomic data, and an accommodative stance by major central banks. Investors have not reacted strongly to the possibility of tax increases in the US nor to the newly proposed infrastructure and social spending plans that together add up to $4.1T, not knowing to what extend the plans will be implemented.
Valuation Neutral
Momentum Neutral
Seasonality Neutral
Macro-Economics Positive


While the supporting factors that pushed equity markets in April should continue into May, valuations are still quite elevated, although justified by the earnings in some sectors, and substantial risks remain: corporate and capital gains tax hikes in the US, new COVID-19 strains, and the possibility of early tapering as a reaction to rising inflation would all pose a threat to equities. This is why investors are quite divided in their view on whether they should “sell in May and go away” or stay put and believe that there is more room for stocks to grow in the upcoming weeks. VIX, which represents the expected volatility of the US stock market, is somewhat elevated, but is still around its lowest levels in over a year.
This might mean that investors are not expecting a market correction but are willing to pay for some insurance against one.
We keep a neutral stance on equities as markets are driven by vaccination speed, recovery, and central banks’ actions.

Alternative Investments

Despite the waning momentum towards the end of the month, there is still upside potential for gold within the next weeks both on the technical and fundamental sides. In March, the metal bounced off the $1675 level twice, but did not break below it. The second time, propelled gold up to end April around $1770 per ounce resulting in over 3% monthly gain. At the same time, such factors as growing demand from Central Banks and Asian consumers, rising inflation, and dollar weakness support gold from the fundamental
EURUSD steadily grew over the past month from 1.17 to 1.21 in the end of April. The trend is likely to continue: the currency pair can reach 1.22-1.23 due to an improving growth outlook in Europe.
After a choppy, but overall positive April, oil price is expected to pick up in May: demand growth, according to OPEC+, will be steady in 2021 as travel resumes. Currently, the upside potential from reopening economies outweighs the risk of the spread of the new COVID-19 variants to countries with lagging vaccinations.
We are neutral on Gold, overweight on commodities. We also prefer private markets to hedge funds.
Note: This report is published by Clarus Capital Group AG


Roger Ganz, Head Asset Management, Clarus Capital Group AG
Dejan RisticPartner, Clarus Capital Group AG


This document has been prepared by Clarus Capital Group AG ("Clarus Capital"). This document and the information contained herein are provided solely for information and marketing purposes. It is not to be regarded as investment research, sales prospectus, an offer or a solicitation of an offer to enter in any investment activity or contractual relation. Please note that Clarus Capital retains the right to change the range of services, the products and the prices at any time without notice and that all information and opinions contained herein are subject to change.
This document is not a complete statement of the markets and developments referred to herein. Past performance and forecasts are not a reliable indicator of future performance. Investment decisions should always be taken in a portfolio context and make allowance for your personal situation and consequent risk appetite and risk tolerance. This document and the products and services described herein are generic in nature and do not consider specific investment objectives, financial situation or particular needs of any specific recipient. Investors should note that security values may fluctuate, and that each security’s price or value may rise or fall. Accordingly, investors may receive back less than originally invested. Individual client accounts may vary. Investing in any security involves certain risks called non-diversifiable risk. These risks may include market risk, interest-rate risk, inflation risk, and event risk. These risks are in addition to any specific, or diversifiable, risks associated with particular investment styles or strategies.
Clarus Capital does not provide legal or tax advice and makes no representations as to the tax treatment of assets or the investment returns thereon, either in general or with reference to specific client's circumstances and needs. Recipients should obtain independent legal and tax advice on the implications of the products and services in the respective jurisdiction before investing. Certain services and products are subject to legal provisions and cannot be offered world-wide on an unrestricted basis. In particular, this document is not intended for distribution in jurisdictions where its distribution by Clarus Capital would be restricted. Clarus Capital specifically prohibits the redistribution of this document in whole or in part without the written permission of Clarus Capital and Clarus Capital accepts no liability whatsoever for the actions of third parties in this respect. Neither Clarus Capital nor any of its partners, employees or finders accepts any liability for any loss or damage arising out of the use of all or any part of this document. Source of all information is Clarus Capital unless otherwise stated. Clarus Capital makes no representation or warranty relating to any information herein which is derived from independent sources. Please consult your client advisor if you have any questions.

Markets Monthly Pulse (June '21)
Monthly Pulse (June '21)

Economic Outlook With price growth data in the US and Europe exceeding expectations, US President proposing more and more enormous spending plans - the latest one amounting to $6T - and omnipresent supply shortages,.

Learn More
Markets Monthly Pulse (April '21)
Monthly Pulse (April '21)

Recovery and reopening paths are diverging across the world: on the one hand, some countries like Australia, New Zealand, China have almost eliminated COVID19 within their borders through strict repeated lockdowns, that.

Learn More
Markets Monthly Pulse (March '21)
Monthly Pulse (March '21)

New infections and deaths from COVID-19 have been steadily falling in the world for several consecutive weeks.

Learn More